Lyme Disease Treatment Market | Trends,Size, Growth, Share, COVID-19 Impact ...
Disease can be an infectious disease, caused due to the bacterium – Borrelia burgdorferi, which is transmitted to humans through bites of infected adult black-legged ticks. Most human infections are due to bites of nymphs (immature tick). Ticks can attach to any part of the human body and can transmit the infection, if attached to the host body for 36 to 48 hours. Blacklegged ticks are accountable for spreading Lyme disease in the northeastern, mid-Atlantic, and north-central aspects of the U.S. However, western black-legged ticks spread Lyme disease in the regions across the Pacific Coast. These regions are thus, anticipated to witness rapid growth of industry for Lyme disease treatment in the near future.
The major players operating in the Lyme Disease Treatment Market include Lupin Ltd, Mylan N.V., Sun Pharmaceuticals Industries Ltd., Pfizer Inc., G&W Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, GlaxoSmithKline plc., and Hospira Inc.
Antibiotics are found to be the very best treatment for Lyme disease. Patients with early stages of Lyme disease recover rapidly and completely with appropriate antibiotics such as for instance doxycycline, amoxicillin, and cefuroxime axetil. Patients with certain neurological or cardiac illness might be treated with intravenous ceftriaxone. Patients bearing chronic symptoms of Lyme disease for over 6 months, can recover within a few weeks, through oral antibiotic treatment.
In accordance with International Lyme and Associated Disease Society (ILADS), Lyme disease is frequently difficult to diagnose and treat, causing persistent infections. ILADS recommends individualized treatment based on the severity of symptoms, tick-borne coinfections, and patient's response to treatment. However, no single antibiotic or combination of antibiotics appears to be capable of eliminating the Lyme disease infection. Therefore, the prevailing cases of Lyme disease and large scope to produce the perfect antibiotic for treatment, are expected to improve the Lyme Disease Treatment Market in the near future.
Comments
Post a Comment